Add Yahoo as a preferred source to see more of our stories on Google. A test designed to identify biomarkers associated with autism in infants and young children is now available to the public in most ...

NeuroQure, a startup diagnostics medtech that formed in 2023, has launched a first-of-its-kind test that can identify autism risk at birth, allowing for earlier and more fine-tuned therapies at ...

Adults can have autism, and for many people, this condition is not diagnosed until adulthood. If you are wondering whether you or someone you care about has autism, screening tests are available, and ...

Relying on a single strand of hair, LinusBio is launching its diagnostic aid for autism spectrum disorder—with a test designed to chart a child’s environmental exposures over time. The company aims to ...

Please provide your email address to receive an email when new articles are posted on . ClearStrand-ASD was designed to help clinicians rule out autism in children aged 1 to 36 months. The technology ...

Background: Among patients with autism spectrum disorders (ASD) evaluated in our clinic, there appears to be a subset that can be clinically distinguished from other ASD children because of frequent ...

The company’s ASD Insight test analyzes a small skin sample to diagnose autism in children for earlier prevention NeuroQure, a biotech startup using patented technologies from UCI, just launched a ...

A simple urine test may help identify children at risk for autism sooner than current assessments - opening the door for earlier diagnosis and treatment, and better long-term outcomes for children who ...

According to the advocacy group Autism Speaks, one in every 36 U.S. children has an autism spectrum disorder (ASD). Early diagnosis is crucial to helping to treat the condition, but how is a diagnosis ...

A test designed to identify biomarkers associated with autism in infants and young children is now available to the public in most states. LinusBio, a New Jersey-based startup, on Thursday launched ...